Abrocitinib-A promising option for patients with refractory bullous pemphigoid

被引：4
|
作者：
Jiang, Weiwei [1 ]
Ma, Xiuliang [1 ]
Guo, Tao [1 ]
Song, Mengmeng [1 ]
Zhang, Junling [1 ,2 ]
机构：
[1] Tianjin Acad Tradit Chinese Med, Affiliated Hosp, Tianjin Inst Integrat Dermatol, Dept Dermatol, Tianjin, Peoples R China
[2] Tianjin Acad Tradit Chinese Med, Dept Dermatol, Affiliated Hosp, 354 Beima Rd, Tianjin 300120, Peoples R China
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2024年 / 38卷 / 01期
关键词：
D O I：
10.1111/jdv.19475
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E119 / E121
页数：3
相关论文
共 50 条
  • [1] Efficacy of interferon-γ in patients with refractory bullous pemphigoid
    Nakama, Takekuni
    Ishii, Norito
    Ono, Fumitake
    Hamada, Takahiro
    Yasumoto, Shinichiro
    Hashimoto, Takashi
    JOURNAL OF DERMATOLOGY, 2007, 34 (11): : 737 - 745
  • [2] Immunoadsorption: adjuvant Therapy option for Patients with severe bullous Pemphigoid
    Schulze, F.
    van Beek, N.
    Kasperkiewicz, M.
    Nitschke, M.
    Meier, M.
    Zillikens, D.
    Schmidt, E.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 103 - 103
  • [3] Minocycline as a therapeutic option in bullous pemphigoid
    Loo, WJ
    Kirtschig, G
    Wojnarowska, F
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2001, 26 (05) : 376 - 379
  • [4] Characteristics of patients with bullous pemphigoid: comparison of classic bullous pemphigoid to non-bullous pemphigoid
    Ben Mordehai, Y.
    Faibish, H.
    Astman, N.
    Greenberger, S.
    Barzilai, A.
    Baum, S.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (01) : 161 - 165
  • [5] Omalizumab: an underutilized treatment option in bullous pemphigoid patients with co-morbidities
    De, D.
    Kaushik, A.
    Handa, S.
    Mahajan, R.
    Schmidt, E.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (07) : E469 - E472
  • [6] Immunoadsorption as adjuvant Therapy option for severe bullous Pemphigoid: Experience with 20 Patients
    Schulze, F.
    van Beek, N.
    Kasperkiewicz, M.
    Zillikens, D.
    Schmidt, E.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2015, 13 : 137 - 137
  • [7] Adjuvant immunoadsorption in severe and/or refractory bullous pemphigoid
    Huebner, F.
    Kasperkiewicz, M.
    Knuth-Rehr, D.
    Shimanovich, I.
    Suefke, S.
    Muck, P.
    Zil-likens, D.
    Schmidt, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : S276 - S276
  • [8] Efficacy of rituximab in a case of refractory bullous pemphigoid
    Reguiai, Z.
    Tchen, T.
    Perceau, G.
    Bernard, P.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2009, 136 (05): : 431 - 434
  • [9] Vorinostat for treatment-refractory bullous pemphigoid
    Blanchard, Gabriela
    Solly, Francoise
    Basset, Valentin
    Fontao, Lionel
    Blanchard, Mael
    Guenova, Emmanuella
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (10) : E1218 - E1220
  • [10] Dapsone: a forgotten and underestimated treatment option for bullous pemphigoid?
    Zychowska, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (05) : 1156 - 1157
12345